![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Profile
Contact Information
Contact: Jen Ponder
Phone: 704-247-9179
Fax: 704-247-9178
Email: Click here to see email.
Website: http://www.djlresearch.com
Center Information
Jen Ponder
Director of Clinical Relations
431 N Wendover Rd Charlotte NC 28211
Phone: 704-247-9179
Fax: 704-247-9178
Email: jen.ponder@djlresearch.com
www.djlresearch.com
www.djlresearch.com
Overview:
DJL Clinical Research is an Investigative Site Network based in Charlotte NC, founded by Jane Box MD and Patrick Box MD. An Investigative Site Network (ISN) is defined as a group of independent clinical research sites based upon specific qualification criteria that function as one entity. When compared to single site models, Network Site Models lead to increased regulatory readiness, enrollment rates, and decreased query rates.
Research experience:
DJL is physician owned and managed - with more than 35 years of experience conducting pharmaceutical research. We partner with independent physician practices to integrate high quality and efficient clinical research into your daily practice, with direct access to experienced investigators. Most importantly we provide physician to physician training with ongoing support.
Currently our partner specialties include:
• Asthma Allergy
• Audiology
• Cardiology
• Dermatology
• Gastroenterology
• Gynecology
• Internal Medicine
• Neurology
• Oncology
• Ophthalmology
• Rheumatology
Over the years we have worked with many Sponsors/CROs such as Lilly, Pfizer, Merck, AbbVie, Concert, Roche, Regeneron, Genentech, AstraZeneca, Novartis, Amgen, Janssen, Biogen, BMS, Celgene, Gilead, Idorsia, UCB, Sanofi, Viela, GSK, Myovant, and NovoCure, IQVIA, ICON, Parexel, PPD, Clintrax Global, Covance/LabCorp, DrugDev/INC Research, MedPace, PRA, WorldWide Clinical Trials, Syneos Health, LLC, RHO World.
Facility description:
DJL Clinical Research facilities include:
• Central locations
o Close proximity to hospitals, airports and public transportation
• Fully equipped lab
o -80° C freezer
o -20° C freezer
o refrigerated and ambient centrifuge
• Secured and temperature monitored drug storage
• Convenient to imaging facilities
• Infusion, PK and ECG capabilities
• Staff trained in AED
• Network Standard Operating Procedures
Investigator experience:
To see a list of our current partner sites please follow this link to our website which includes CVs: https://www.djlresearch.com/sponsors
Staff expertise:
Deepa Jagannathan CAO--10 years
Kathy Hulla Financial Controller--13 years
Ashley Philbeck--Quality and Regulatory Specialist/CPhT--12 years
Jen Ponder--Director of Clinical Relations--15+ years
Patient demographics:
With our locations being scattered geographically throughout Charlotte and into South Carolina, we have a strong presence in areas with diverse populations. We have also participated in a several pediatric trials. Additionally, being an Investigative Site Network allows us to utilize all patient databases with our partner sites. We have specialists that refer patients to other specialists for their healthcare and for participation in clinical trials.
Other information:
Working only with independent physicians allows us to utilize the central IRB. Our quick turn around with contracting, budgeting and regulatory does expedite study start up.
Additional instructions:
For any additional information, please contact Jen Ponder, jen.ponder@djlresearch.com. Please visit www.djlresearch.com for more information or reach out to us directly.